I have just returned from the CHIF/ABA2001 Conference which was held in Sydney, where we saw, among other things, the Premier of NSW launch the biotechnology strategy for NSW (ie "BioFirst").
It was a great privilege for me to join with Professor John Shine, who was Chair of the CHIF/ABA2001 Steering Committee for the Conference in welcoming delegates to what was a quite significant event. The CHIF Conferences, of which this year's is the third, are held every other year and are characterised by a focus on early stage commercialisation of health science which makes it perhaps the only conference of its type in Australia. This was the vision of its founders, who saw the potential in the extensive research base in Australian medical science.
The CHIF/ABA2001 Conference was significant because of the "partnerships" involved, a theme I developed for my opening remarks at the Conference and which I share with you here in this article. ...
